DGX (Quest Diagnostics) Receipts from Customers


DGX Quest Diagnostics Inc DGX
83 GF Score
Price $202.44
GF Value $187.33
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Quest Diagnostics Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

DGX
83GF Score
Quest Diagnostics Inc DGX
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Quest Diagnostics (DGX) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of $202.44 is trading 8.1% above its estimated GF Value™ of $187.33. GuruFocus considers Quest Diagnostics to be Fairly Valued.

Key valuation signals for DGX:

  • Receipts from Customers:
  • GF Value™: $187.33 vs. price of $202.44 (8.1% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the DGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
83GF Score

Get the complete analysis for DGX

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$202.44
Price
$187.33
GF Value